Patricia Latham, MD

Associate Professor, Departments of Pathology and Medicine, School of Medicine and Health Sciences, The George Washington University


Office Phone: (202) 994-5057

Current HIV/AIDS Research Activities:

  • Women's Interagency HIV Study (WIHS) III, NIH #A1034994,Co-investigator, Reference Pathologist Hepatitis working Group, 2002-Present
  • "The reliability of serum markers in predicting hepatic activity and fibrosis as seen on liver biopsy in patients with chronic hepatitis C and HIV" - a study funded by Pfizer, Inc. as part of a contract to provide pathology support to a study of nelfinavir (see Service Activities), 2005-Present
  • The prevalence and pathology of Hepatocellular carcinoma in the setting of hepatitis C and HIV co-infection, 2010-Present

Current HIV/AIDS Clinical Activities:

  • Sign out all liver biopsies done on patients with HIV/AIDS
  • Care for patients with HIV/ AIDS who have hepatitis due to virus (hepatitis B and C) or hepatotoxicity due to drugs for HIV/ AIDS

Current HIV/AIDS Service Activities:

  • Consultant and Investigator, An Open Label Study To Evaluate The Safety and Pharmacokinetics of Nelfinavir in HIV / Hepatitis C (HCV) Co-Infected Subjects With Hepatic Dysfunction, Pfizer Inc., New York, NY, 2005-Present
  • Member of Data Monitoring Committee, Multicenter Open- Label Expanded Access Trial of Maraviroc, Pfizer Inc., New York, NY, 2007-13